Market fit Target buyers in health systems, airports, and large venues seeking rapid, portable pathogen testing; position Inventive Health as a scalable mobile solution that complements existing public health screening programs.

Strategic partnerships Leverage collaboration with Virusight Diagnostic and Sheba Medical Centre to showcase credibility; pursue joint demonstrations with government health agencies and major transport hubs to accelerate pilot deployments.

Technology edge Highlight AI/ML driven spectral analysis and cloud-based delivery to differentiate from traditional lab tests; emphasize speed, accuracy, and ease of deployment for mass screening at scale.

Geographic readiness Focus on Australia first with potential export to nearby markets and OECD countries; articulate use cases for airports, aged care facilities, and sporting events to align with regional health initiatives.

Financial outlook With revenue in the 1–10M range, target mid-market health technology buyers and private health networks; propose pilot programs and volume licensing to drive recurring revenue and expand customer base.